Home / Inspections / 1280309

FDA Inspection 1280309 — Eurofins Biopharma Product Testing Ireland Limited

Eurofins Biopharma Product Testing Ireland Limited — FEI 3002807550

The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on June 20, 2025 in Dungarvan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 20, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dungarvan (Ireland)

Facility

Other inspections at this facility

  • 1270954 (VAI Fri May 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008821 (NAI Fri Feb 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 826551 (NAI Fri Mar 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 618581 (NAI Wed Sep 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources